79 related articles for article (PubMed ID: 33184464)
1. Utilizing public health data to geotarget hepatitis C virus elimination approaches in urban and rural Michigan.
Weinheimer-Haus EM; Yu X; Singal AG; Naylor KB; Ammori C; Coyle J; Nallamothu BK; Witala W; Zhu J; Waljee AK
J Viral Hepat; 2021 Feb; 28(2):440-444. PubMed ID: 33184976
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus.
Khanam A; Kottilil S; Wilson E
Sci Rep; 2020 Nov; 10(1):19924. PubMed ID: 33199783
[TBL] [Abstract][Full Text] [Related]
3. Effect of viral eradication with direct-acting antiviral agents on iron parameters in patients with chronic hepatitis c and hyperferritinemia.
Castiella A; José Sánchez-Iturri M; Urreta I; Torrente S; Alcorta A; Zapata E
Can Liver J; 2023 Dec; 6(4):412-416. PubMed ID: 38152323
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms Related to Iron Homeostasis Associate with Liver Disease in Chronic Hepatitis C.
Wróblewska A; Woziwodzka A; Rybicka M; Bielawski KP; Sikorska K
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632052
[TBL] [Abstract][Full Text] [Related]
5. The Emerging Role of Ferroptosis in Various Chronic Liver Diseases: Opportunity or Challenge.
Zhu L; Luo S; Zhu Y; Tang S; Li C; Jin X; Wu F; Jiang H; Wu L; Xu Y
J Inflamm Res; 2023; 16():381-389. PubMed ID: 36748023
[TBL] [Abstract][Full Text] [Related]
6. Iron as a therapeutic target in chronic liver disease.
Kouroumalis E; Tsomidis I; Voumvouraki A
World J Gastroenterol; 2023 Jan; 29(4):616-655. PubMed ID: 36742167
[TBL] [Abstract][Full Text] [Related]
7. Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation.
Dufrusine B; Valentinuzzi S; Bibbò S; Damiani V; Lanuti P; Pieragostino D; Del Boccio P; D'Alessandro E; Rabottini A; Berghella A; Allocati N; Falasca K; Ucciferri C; Mucedola F; Di Perna M; Martino L; Vecchiet J; De Laurenzi V; Dainese E
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613462
[TBL] [Abstract][Full Text] [Related]
8. Metabolic aspects of hepatitis C virus.
El-Kassas M; Awad A
World J Gastroenterol; 2022 Jun; 28(22):2429-2436. PubMed ID: 35979265
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus: A critical approach to who really needs treatment.
Kouroumalis E; Voumvouraki A
World J Hepatol; 2022 Jan; 14(1):1-44. PubMed ID: 35126838
[TBL] [Abstract][Full Text] [Related]
10. Calprotectin in viral systemic infections-COVID-19 versus hepatitis C virus.
Toma L; Dodot M; Zgura A; Bacalbasa N; Silaghi A; Simu R; Isac T; Mercan-Stanciu A
Clin Exp Med; 2022 May; 22(2):311-317. PubMed ID: 34254197
[TBL] [Abstract][Full Text] [Related]
11. Metabolic complications of hepatitis C virus infection.
Chaudhari R; Fouda S; Sainu A; Pappachan JM
World J Gastroenterol; 2021 Apr; 27(13):1267-1282. PubMed ID: 33833481
[TBL] [Abstract][Full Text] [Related]
12. Evolution of ferritin levels in hepatitis C patients treated with antivirals.
Chang ML; Hu JH; Yen CH; Chen KH; Kuo CJ; Lin MS; Lee CH; Chen SC; Chien RN
Sci Rep; 2020 Nov; 10(1):19744. PubMed ID: 33184464
[TBL] [Abstract][Full Text] [Related]
13. Long-term renal function alterations in hepatitis C patients with SVRs: Impacts of therapies and mixed cryoglobulinemia.
Chang ML; Cheng JS; Chen WT; Hsu CW; Chen KH; Chen YC; Chien RN
J Infect Public Health; 2024 Mar; 17(3):486-494. PubMed ID: 38280352
[TBL] [Abstract][Full Text] [Related]
14. Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study.
Lee H; Chien RN; Pao LH; Kuo CJ; Huang PH; Chang ML
Cells; 2021 Oct; 10(11):. PubMed ID: 34831156
[TBL] [Abstract][Full Text] [Related]
15. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
Chang ML; Cheng JS; Chuang YH; Pao LH; Wu TS; Chen SC; Chang MY; Chien RN
Front Immunol; 2022; 13():823160. PubMed ID: 35371039
[TBL] [Abstract][Full Text] [Related]
16. Critical role of triglycerides for adiponectin levels in hepatitis C: a joint study of human and HCV core transgenic mice.
Chang ML; Hu JH; Pao LH; Lin MS; Kuo CJ; Chen SC; Fan CM; Chang MY; Chien RN
BMC Immunol; 2021 Aug; 22(1):54. PubMed ID: 34380427
[TBL] [Abstract][Full Text] [Related]
17. Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
Casey JL; Feld JJ; MacParland SA
Cells; 2019 Apr; 8(4):. PubMed ID: 30959825
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
